These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2422264)

  • 21. Substance P and stress-induced changes in macrophages.
    Chancellor-Freeland C; Zhu GF; Kage R; Beller DI; Leeman SE; Black PH
    Ann N Y Acad Sci; 1995 Dec; 771():472-84. PubMed ID: 8597423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of macrophage lysosomal enzyme secretion by agents acting at the plasma membrane.
    Dean RT; Hylton W; Allison AC
    Exp Cell Biol; 1979; 47(6):454-62. PubMed ID: 520650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tachykinin receptor cross-talk. Immunological cross-reactivity between the external domains of the substance K and substance P receptors.
    Parnet P; Mitsuhashi M; Turck CW; Kerdelhue B; Payan DG
    Brain Behav Immun; 1991 Mar; 5(1):73-83. PubMed ID: 1712653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Substance P receptor mediated macrophage responses.
    Marriott I; Bost KL
    Adv Exp Med Biol; 2001; 493():247-54. PubMed ID: 11727773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Substance P induces a rise in intracellular calcium concentration in human T lymphocytes in vitro: evidence of a receptor-independent mechanism.
    Kavelaars A; Jeurissen F; von Frijtag Drabbe Künzel J; Herman van Roijen J; Rijkers GT; Heijnen CJ
    J Neuroimmunol; 1993 Jan; 42(1):61-70. PubMed ID: 7678598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of activation in alveolar macrophage-mediated suppression of the plaque-forming cell response.
    Mbawuike IN; Herscowitz HB
    Infect Immun; 1988 Mar; 56(3):577-81. PubMed ID: 2830191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of substance P binding to human monocytes/macrophages.
    Lucey DR; Novak JM; Polonis VR; Liu Y; Gartner S
    Clin Diagn Lab Immunol; 1994 May; 1(3):330-5. PubMed ID: 7496971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Substance P and alveolar macrophages: effects on oxidative metabolism and eicosanoid production.
    Murris-Espin M; Pinelli E; Pipy B; Leophonte P; Didier A
    Allergy; 1995 Apr; 50(4):334-9. PubMed ID: 7573817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure, functions, and mechanisms of substance P receptor action.
    Krause JE; Takeda Y; Hershey AD
    J Invest Dermatol; 1992 Jun; 98(6 Suppl):2S-7S. PubMed ID: 1316925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuro-endocrine interaction on lymphocytes. Testosterone-induced modulation of the lymphocyte substance P receptor.
    Parnet P; Payan DG; Kerdelhué B; Mitsuhashi M
    J Neuroimmunol; 1990 Jul; 28(2):185-8. PubMed ID: 1694535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of anti-idiotypic antibodies as probes for in vitro and in vivo identification of substance P receptor.
    Couraud JY; Maillet S; Conrath M; Calvino B; Pradelles P
    Mol Chem Neuropathol; 1990 Jan; 12(1):71-82. PubMed ID: 1703763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Substance P and the inflammatory and immune response.
    Mantyh PW
    Ann N Y Acad Sci; 1991; 632():263-71. PubMed ID: 1719871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of the release of prostaglandins, leukotrienes and lysosomal acid hydrolases from macrophages by selective inhibitors of lecithin biosynthesis.
    Bonney RJ; Wightman PD; Dahlgren ME; Sadowski SJ; Davies P; Jensen N; Lanza T; Humes JL
    Biochem Pharmacol; 1983 Jan; 32(2):361-6. PubMed ID: 6553500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can aprepitant used for nausea and vomiting be good gastrointestinal complaints?
    Ugan RA; Un H; Kose D; Cadirci E; Bal Tastan T; Yayla M; Halici Z
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Dec; 393(12):2463-2472. PubMed ID: 32743741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene expression analysis of neuropeptides in oral mucosa during periodontal disease in non-human primates.
    Ferrin J; Kirakodu S; Jensen D; Al-Attar A; Peyyala R; Novak MJ; Dawson D; Al-Sabbagh M; Stromberg AJ; Orraca L; Gonzalez-Martinez J; Burgos A; Ebersole JL; Gonzalez OA
    J Periodontol; 2018 Jul; 89(7):858-866. PubMed ID: 29676776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relation between pulpal neuropeptides and dental caries.
    Kangarlou Haghighi A; Nafarzadeh S; Shantiaee Y; Naseri M; Ahangari Z
    Iran Endod J; 2010; 5(3):113-6. PubMed ID: 24778684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inflammatory and immune pathways in the pathogenesis of periodontal disease.
    Cekici A; Kantarci A; Hasturk H; Van Dyke TE
    Periodontol 2000; 2014 Feb; 64(1):57-80. PubMed ID: 24320956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiation protection following nuclear power accidents: a survey of putative mechanisms involved in the radioprotective actions of taurine during and after radiation exposure.
    Christophersen OA
    Microb Ecol Health Dis; 2012; 23():. PubMed ID: 23990836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurokinin-1 receptor: functional significance in the immune system in reference to selected infections and inflammation.
    Douglas SD; Leeman SE
    Ann N Y Acad Sci; 2011 Jan; 1217():83-95. PubMed ID: 21091716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Temporal effects of topical morphine application on cutaneous wound healing.
    Rook JM; Hasan W; McCarson KE
    Anesthesiology; 2008 Jul; 109(1):130-6. PubMed ID: 18580183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.